Life ScienceCompany
iNova Pharmaceuticals Ownership
Who owns iNova Pharmaceuticals?
iNova Pharmaceuticals is owned by Bourne Partners Strategic Capital, Pacific Equity Partners and The Carlyle Group. It was acquired on June 8, 2017.
Is iNova Pharmaceuticals PE-backed?
Yes. iNova Pharmaceuticals is owned by private equity investors Bourne Partners Strategic Capital, Pacific Equity Partners and The Carlyle Group.
Was iNova Pharmaceuticals formerly PE-backed?
Yes. iNova Pharmaceuticals was formerly owned by 2 private investors.
iNova Pharmaceuticals Business Overview
Where is iNova Pharmaceuticals headquartered?
iNova Pharmaceuticals is headquartered in Chatswood, Australia.
What sector is iNova Pharmaceuticals in?
iNova Pharmaceuticals is a life science company.
When was iNova Pharmaceuticals founded?
iNova Pharmaceuticals was founded in 1958.
Life Science M&A Summary in 2017
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.
Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.